[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO2005020I1 - Caspofungin, eventuelt i form av et farmasøytisk akseptabelt salt særlig caspofunginacetat - Google Patents

Caspofungin, eventuelt i form av et farmasøytisk akseptabelt salt særlig caspofunginacetat

Info

Publication number
NO2005020I1
NO2005020I1 NO2005020C NO2005020C NO2005020I1 NO 2005020 I1 NO2005020 I1 NO 2005020I1 NO 2005020 C NO2005020 C NO 2005020C NO 2005020 C NO2005020 C NO 2005020C NO 2005020 I1 NO2005020 I1 NO 2005020I1
Authority
NO
Norway
Prior art keywords
caspofungin
optionally
pharmaceutically acceptable
acceptable salt
acetate
Prior art date
Application number
NO2005020C
Other languages
English (en)
Other versions
NO2005020I2 (no
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21867140&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2005020(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO2005020I1 publication Critical patent/NO2005020I1/no
Publication of NO2005020I2 publication Critical patent/NO2005020I2/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Vapour Deposition (AREA)
NO2005020C 1993-03-16 2005-09-13 Caspofungin, eventuelt i form av et farmasoeytisk akseptabelt salt saerlig caspofungiacetat NO2005020I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/032,847 US5378804A (en) 1993-03-16 1993-03-16 Aza cyclohexapeptide compounds
PCT/US1994/002580 WO1994021677A1 (en) 1993-03-16 1994-03-10 Aza cyclohexapeptide compounds

Publications (2)

Publication Number Publication Date
NO2005020I1 true NO2005020I1 (no) 2005-09-13
NO2005020I2 NO2005020I2 (no) 2008-12-01

Family

ID=21867140

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19953648A NO318372B1 (no) 1993-03-16 1995-09-15 Azasykloheksapeptidforbindelser, antimikrobielt preparat og anvendelse av disse forbindelser ved fremstilling av et farmasoytisk preparat.
NO2005020C NO2005020I2 (no) 1993-03-16 2005-09-13 Caspofungin, eventuelt i form av et farmasoeytisk akseptabelt salt saerlig caspofungiacetat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19953648A NO318372B1 (no) 1993-03-16 1995-09-15 Azasykloheksapeptidforbindelser, antimikrobielt preparat og anvendelse av disse forbindelser ved fremstilling av et farmasoytisk preparat.

Country Status (33)

Country Link
US (3) US5378804A (no)
EP (1) EP0620232B1 (no)
JP (1) JP2568474B2 (no)
KR (1) KR100329693B1 (no)
CN (1) CN1098274C (no)
AT (1) ATE186736T1 (no)
AU (1) AU668804B2 (no)
BG (1) BG63047B1 (no)
BR (2) BR9406009A (no)
CA (1) CA2118757C (no)
CZ (1) CZ286235B6 (no)
DE (2) DE69421639T2 (no)
DK (1) DK0620232T3 (no)
ES (1) ES2139043T3 (no)
FI (1) FI109542B (no)
GR (1) GR3031872T3 (no)
HK (1) HK1008674A1 (no)
HR (1) HRP940161B1 (no)
HU (2) HU217614B (no)
IL (1) IL108892A (no)
LU (1) LU90875I2 (no)
LV (1) LV12574B (no)
NL (1) NL300076I2 (no)
NO (2) NO318372B1 (no)
NZ (1) NZ263360A (no)
PL (1) PL179261B1 (no)
RO (1) RO113246B1 (no)
RU (1) RU2122548C1 (no)
SI (1) SI9420013B (no)
SK (1) SK282527B6 (no)
UA (1) UA59329C2 (no)
WO (1) WO1994021677A1 (no)
ZA (1) ZA941807B (no)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874403A (en) * 1992-10-15 1999-02-23 Merck & Co., Inc. Amino acid conjugates of cyclohexapeptidyl amines
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
EP0779895B1 (en) * 1994-08-23 1999-11-17 Merck & Co. Inc. An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
AU691743B2 (en) * 1995-01-26 1998-05-21 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5552521A (en) * 1995-02-10 1996-09-03 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
AU707664B2 (en) * 1995-11-09 1999-07-15 Merck & Co., Inc. Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
PE63998A1 (es) * 1996-04-19 1998-10-30 Merck & Co Inc Composiciones anti-fungosas
HRP970318B1 (en) * 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
USRE38984E1 (en) * 1996-09-12 2006-02-14 Merck & Co., Inc. Antifungal combination therapy
DE69724626T2 (de) * 1996-09-12 2004-07-29 Merck & Co., Inc. Fungizide kombinationstherapie
US5854212A (en) * 1996-10-23 1998-12-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
US5936062A (en) * 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
JP2003505468A (ja) * 1999-07-27 2003-02-12 アヴェンティス ファルマ ドイチェラント ゲーエムベーハー 新規なシクロヘキサペプチド化合物、それらの製造方法及びそれらの医薬品としての使用
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
JP4664912B2 (ja) * 2003-07-22 2011-04-06 セラヴァンス, インコーポレーテッド グリコペプチド抗菌剤と組み合わせたエキノカンジン抗真菌剤の使用
EP1730180A4 (en) * 2004-02-24 2008-06-18 Commw Scient Ind Res Org ANTIFUNGAL PEPTIDES
EP1785432A1 (en) * 2005-11-15 2007-05-16 Sandoz AG Process and intermediates for the synthesis of caspofungin.
JP5373606B2 (ja) * 2006-07-26 2013-12-18 サンド・アクチエンゲゼルシヤフト カスポファンギン製剤
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US20100137197A1 (en) * 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
WO2009142761A1 (en) * 2008-05-21 2009-11-26 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Caspofungin bo free of caspofungin co
US8048853B2 (en) * 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
EP2240507A2 (en) * 2008-06-25 2010-10-20 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
KR20110011704A (ko) * 2008-06-25 2011-02-08 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 카스포펀진 불순물 a를 함유하지 않는 카스포펀진
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
TW201024322A (en) * 2008-12-31 2010-07-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate
WO2010108637A1 (en) 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN101602795B (zh) * 2009-07-20 2011-12-21 中国人民解放军第二军医大学 环六脂肽胺类抗真菌化合物及其盐类和制备方法
EP2463293A4 (en) * 2009-08-06 2013-06-05 Shanghai Techwell Biopharm Co AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE
US8751760B2 (en) * 2009-10-01 2014-06-10 Dell Products L.P. Systems and methods for power state transitioning in an information handling system
CN101792486A (zh) * 2010-04-12 2010-08-04 浙江海正药业股份有限公司 一种合成醋酸卡泊芬净的方法
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
UA111599C2 (uk) 2010-09-20 2016-05-25 Кселлія Фармасьютікалз Апс Композиція каспофунгіну
US8927690B2 (en) * 2010-09-29 2015-01-06 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
KR101514904B1 (ko) * 2010-09-30 2015-04-23 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 사이클릭 리포펩타이드 화합물 또는 그의 염의 정제방법
CN102367267B (zh) 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
WO2012093293A1 (en) * 2011-01-03 2012-07-12 Biocon Limited Process for preparation of caspofungin acetate and intermediates
CN102618606B (zh) * 2011-01-30 2014-09-10 浙江海正药业股份有限公司 一种棘白菌素生物转化方法
PT2680873T (pt) 2011-03-03 2017-11-01 Cidara Therapeutics Inc Agentes antifúngicos e suas utilizações
CN102746384B (zh) 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
US9321779B2 (en) 2011-04-28 2016-04-26 Unitris Biopharma Co., Ltd. Intermediate for synthesizing caspofungin and preparation method thereof
RS59960B1 (sr) 2012-03-19 2020-03-31 Cidara Therapeutics Inc Dozni režimi za jedinjenja klase ehinokandina
US9636407B2 (en) * 2012-11-20 2017-05-02 Fresenius Kabi Usa, Llc Caspofungin acetate formulations
CN112110991A (zh) * 2014-12-24 2020-12-22 上海天伟生物制药有限公司 一种含氮杂环六肽前体的组合物及其制备方法和用途
WO2017034961A1 (en) 2015-08-21 2017-03-02 Trilogy Therapeutics, Inc. Methods of treating lung infection with caspofungin
US10369188B2 (en) 2016-01-08 2019-08-06 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
WO2017161016A1 (en) 2016-03-16 2017-09-21 Cidara Therapeutics, Inc. Dosing regimens for treatment of fungal infections
WO2017185030A1 (en) * 2016-04-22 2017-10-26 Fresenius Kabi Usa, Llc Caspofungin formulation with low impurities
CA3069423A1 (en) 2017-07-12 2019-01-17 Cidara Therapeutics, Inc. Formulations for the treatment of fungal infections
WO2019157453A1 (en) 2018-02-12 2019-08-15 Trilogy Therapeutics, Inc. Caspofungin compositions for inhalation
EP3620462A1 (en) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Process for the preparation of caspofungin

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE851310A (fr) * 1976-02-12 1977-08-10 Sandoz Sa Nouveaux derives de la tetrahydro-equinocandine b
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
EP0030844A1 (en) * 1979-12-13 1981-06-24 Eli Lilly And Company Recovery process for A-30912 antibiotics
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
DE3030554A1 (de) * 1980-08-13 1982-03-25 Chemische Werke Hüls AG, 4370 Marl Einbrennlacke
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
IL94862A (en) * 1989-06-30 1994-10-07 Merck & Co Inc History of Echinocandin Antifungal Antibiotics, Its Production and Pharmaceutical Preparations Containing It
US5194377A (en) * 1989-06-30 1993-03-16 Merck & Co., Inc. Antibiotic agent
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
US5159059A (en) * 1990-05-29 1992-10-27 Merck & Co., Inc. Process for reduction of certain cyclohexapeptide compounds
IL105048A (en) * 1992-03-19 2001-06-14 Eli Lilly And Company U S Antifungal substances of the cyclic peptide type and a process for their preparation
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
DK0620232T3 (da) 2000-03-13
NL300076I2 (nl) 2002-04-02
RO113246B1 (ro) 1998-05-29
US5792746A (en) 1998-08-11
SK113695A3 (en) 1996-02-07
LV12574A (en) 2000-11-20
JPH06321986A (ja) 1994-11-22
HK1008674A1 (en) 1999-05-14
ES2139043T3 (es) 2000-02-01
SK282527B6 (sk) 2002-10-08
HU9502703D0 (en) 1995-11-28
FI954327A (fi) 1995-09-14
SI9420013A (en) 1996-08-31
NO953648D0 (no) 1995-09-15
CN1119441A (zh) 1996-03-27
SI9420013B (sl) 2002-12-31
CZ286235B6 (cs) 2000-02-16
EP0620232B1 (en) 1999-11-17
DE10299013I1 (de) 2003-01-23
GR3031872T3 (en) 2000-02-29
US5514650A (en) 1996-05-07
UA59329C2 (uk) 2003-09-15
FI109542B (fi) 2002-08-30
BG63047B1 (bg) 2001-02-28
CA2118757C (en) 2002-05-14
ATE186736T1 (de) 1999-12-15
EP0620232A1 (en) 1994-10-19
CZ235895A3 (en) 1996-02-14
HU211890A9 (en) 1995-12-28
RU2122548C1 (ru) 1998-11-27
PL179261B1 (pl) 2000-08-31
ZA941807B (en) 1994-10-13
NL300076I1 (nl) 2002-03-01
WO1994021677A1 (en) 1994-09-29
LV12574B (en) 2001-04-20
HRP940161B1 (en) 2001-04-30
CN1098274C (zh) 2003-01-08
HRP940161A2 (en) 1996-08-31
IL108892A0 (en) 1994-06-24
DE69421639T2 (de) 2000-06-08
HUT73496A (en) 1996-08-28
LU90875I2 (en) 2002-03-04
US5378804A (en) 1995-01-03
BG99999A (bg) 1996-04-30
DE69421639D1 (de) 1999-12-23
AU668804B2 (en) 1996-05-16
DE10299013I2 (de) 2009-11-19
KR100329693B1 (ko) 2002-08-14
KR960701092A (ko) 1996-02-24
NO318372B1 (no) 2005-03-14
IL108892A (en) 1998-07-15
HU217614B (hu) 2000-03-28
JP2568474B2 (ja) 1997-01-08
NO2005020I2 (no) 2008-12-01
CA2118757A1 (en) 1994-09-17
PL310634A1 (en) 1995-12-27
AU5783294A (en) 1994-09-22
BR1100273A (pt) 1999-10-13
NO953648L (no) 1995-11-15
NZ263360A (en) 1997-08-22
BR9406009A (pt) 1995-12-26
FI954327A0 (fi) 1995-09-14

Similar Documents

Publication Publication Date Title
NO2005020I2 (no) Caspofungin, eventuelt i form av et farmasoeytisk akseptabelt salt saerlig caspofungiacetat
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
AU2227992A (en) Conformationally restricted biologically active peptides, methods for their production and uses thereof
UA43323C2 (uk) Антибіотичні похідні глікопептидів, спосіб отримання та фармацевтична композиція
CA2272705A1 (en) Fused bicyclic pyrimidine derivatives
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
DE69631609D1 (en) Tricyclische erythromycinderivate
RU92004562A (ru) Новые цефалоспорины, имеющие в положении 7 замещенный оксииминный радикал, метод их получения и их использование в качестве медикаментов, фармацевтический состав на их основе
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
FI961717A (fi) Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi
DE69118126D1 (de) Derivate von 10,11,12,13-tetra-hydrodesmycosin, Verfahren zu ihrer Herstellung, und ihre Verwendung zur Herstellung von Arzneimitteln
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
AU8060391A (en) Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
IL117302A (en) Cryptophycin derivatives, methods for the production thereof and pharmaceutical compositions containing the same
GB9018263D0 (en) Tricyclo compounds,processes for their production and pharmaceutical compositions containing the same